Nasal tumor in dogs: treatment, prognosis and clinical trials

Dogs · USA & Canada

Understanding nasal tumor

Nasal tumors grow inside the nasal cavity or sinuses and usually cause problems through local invasion. Persistent discharge, nosebleeds, sneezing, noisy breathing or facial changes are common. The exact tumor type still matters, but for many dogs the key issue is how far the disease has extended locally.

What does the prognosis look like?

For dogs treated with radiation, typical survival times in published studies are commonly around 8–18 months. The range is wide because biopsy type and local extent differ. In one recent group, the typical time was about 15 months without destruction of the bone separating the nasal cavity from the brain, versus about 6 months when that barrier was affected. CT and biopsy show whether those figures are relevant.

What matters next

Get a tissue diagnosis and define the local extent before choosing treatment. Nasal cancers can look similar on symptoms but respond differently depending on tumor type. CT is especially useful for showing whether the tumor has reached the orbit, nearby tissues or the barrier toward the brain.

Where are you now?

Biopsy is not done yet

Several tumor types can look similar in the nose, so imaging alone should not be used to choose a cancer-specific treatment when a biopsy can be obtained safely.

Nosebleeds or airflow problems are worsening

Local progression can become the immediate problem before distant spread. Worsening bleeding or breathing may justify accelerating local treatment rather than waiting through a routine queue.

Radiation has already been given or the tumor has recurred

Re-irradiation, systemic treatment, or a trial may be possible in selected cases, but the previous radiation dose and field matter. Keep the treatment summary because a new center will need it.

If you are waiting for oncology

Biopsy and CT should usually come before committing to a cancer-specific treatment because different nasal cancers can look similar. Worsening bleeding, airflow obstruction or neurologic signs can make local treatment more urgent.

Questions to ask your oncologist

What does biopsy show, and how far does CT show the tumor extending?
Is the cribriform plate involved and do lymph nodes need assessment?
Is radiation the main local treatment, and what options remain if the tumor recurs?

How the diagnosis may appear in the record

Nasal carcinoma, sarcoma, lymphoma, melanoma, and other tumors can produce similar symptoms but require different treatment. A biopsy diagnosis should be paired with CT-defined local extent, including bone destruction and involvement near the orbit or cribriform plate. “Nasal mass” alone is not a final cancer diagnosis.

Changes to watch for at home

Track airflow through each nostril, discharge, nosebleeds, sneezing, facial swelling, eye changes, appetite, and sleep. Heavy or persistent bleeding, labored breathing, severe distress, or sudden neurologic signs should not wait for a routine visit.

How it is usually treated

Radiation is the main definitive treatment for most canine nasal tumors because complete surgery is rarely practical. Chemotherapy or targeted drugs may be added for selected histologies or advanced disease. Palliative radiation can be used when the goal is symptom relief rather than long-term local control.

What can affect treatment choices

Tumor type, CT extent, involvement near the brain, severity of bleeding or obstruction, regional nodes and previous radiation or recurrence are the main treatment-changing details.

Tests that may matter

CT of the nasal cavity plus biopsy are the core tests. CT shows local extent, including orbit or cribriform-plate involvement, while biopsy identifies the actual tumor type. Regional lymph-node sampling is added when it could change staging or treatment.

Treatment options available now

3 options currently in our catalog.

Check eligibility

Compassionate-Use Protocol for Advanced Non-Resectable Tumors

UT Southwestern Veterinary Research and Oncology Clinic · USA

Location

Veterinary Research and Oncology Clinic, 5801 Forest Park Rd, Dallas, TX 75235

Study details

Current

What is being offered: Investigational therapy, chemotherapy, immunotherapy and combination approaches under a prospective compassionate-use protocol

Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Min weight kg exclusive: 2.5; min expected survival weeks: 3 weeks; Adequate organ function

May not qualify if: Severe systemic disease

Costs / coverage: ⚪ Owner-paid. The protocol brochure states that owners fully pay for the study, although possible subsidies may be available.

Contact: Paige Neumann, Research Study Coordinator — 214-645-6221; VROC@UTSouthwestern.edu

Official study / enrollment information →

Radiation with or without intra-arterial chemotherapy for canine nasal cancer

UC Davis Veterinary Medical Teaching Hospital · USA

Location

UC Davis Veterinary Medical Teaching Hospital, 1 Garrod Dr, Davis, CA 95616

Study details

Active - Recruiting

What is being offered: Radiation therapy alone or combined with intra-arterial chemotherapy

Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Radiation therapy; Planned radiation

Costs / coverage: 🟡 Partially funded. The study pays for CT scans, chemotherapy administration and part of radiation therapy.

Contact: Dr. Bill Culp — wculp@ucdavis.edu; 530-752-1393

Official study / enrollment information →

Transarterial embolization for canine nasal tumors

UC Davis Veterinary Medical Teaching Hospital · USA

Location

UC Davis Veterinary Medical Teaching Hospital, 1 Garrod Dr, Davis, CA 95616

Study details

Active - Recruiting

What is being offered: Transarterial embolization of the arterial supply to the nasal tumor

Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Ct screening

May not qualify if: Adjacent structure invasion

Costs / coverage: 🟡 Partially funded. The study covers two PET/CT scans and associated anesthesia; owners pay for TAE, the eligibility CT if the dog cannot enroll, and treatment of complications.

Contact: Dr. William Culp — wculp@ucdavis.edu; 530-752-1393

Official study / enrollment information →